ProPhase Labs Files 8-K with Corporate Updates
Ticker: PRPH · Form: 8-K · Filed: Jul 23, 2025 · CIK: 868278
| Field | Detail |
|---|---|
| Company | Prophase Labs, INC. (PRPH) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-disclosure, financial-statements, 8-k
TL;DR
ProPhase Labs filed an 8-K on 7/23/25 detailing corporate info and financial statements.
AI Summary
ProPhase Labs, Inc. filed an 8-K on July 23, 2025, reporting on various events and financial statements. The filing details the company's principal executive offices located at 626 RXR Plaza, 6th Floor, Uniondale, New York, 11556, and confirms its incorporation in Delaware. The report also includes information about its standard industrial classification as Pharmaceutical Preparations.
Why It Matters
This 8-K filing provides essential corporate information and updates for ProPhase Labs, Inc., which is crucial for investors and stakeholders to stay informed about the company's operational and financial status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.
Key Numbers
- 000-21617 — SEC File Number (Identifies the company's filing with the SEC.)
- 23-2577138 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- ProPhase Labs, Inc. (company) — Filer of the 8-K report
- July 23, 2025 (date) — Date of the earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 626 RXR Plaza, 6th Floor, Uniondale, New York 11556 (location) — Address of principal executive offices
- 23-2577138 (identifier) — I.R.S. Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing for ProPhase Labs, Inc.?
The primary purpose is to report on various corporate events and financial statements as of July 23, 2025, including details about its principal executive offices and jurisdiction of incorporation.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 23, 2025.
Where are ProPhase Labs, Inc.'s principal executive offices located?
ProPhase Labs, Inc.'s principal executive offices are located at 626 RXR Plaza, 6th Floor, Uniondale, New York 11556.
In which state is ProPhase Labs, Inc. incorporated?
ProPhase Labs, Inc. is incorporated in Delaware.
What is ProPhase Labs, Inc.'s Standard Industrial Classification code?
ProPhase Labs, Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 23, 2025 regarding ProPhase Labs, Inc. (PRPH).